文献速递神经核医学肿瘤 PET/CT

[18F]FDG PET/MRI 在儿童局灶性癫痫中的应用

[18F]FDG PET/MRI in Pediatric Focal Epilepsies.
PubMed 文献 · J Nucl Med · 2026-08-03

联合PET/MRI读片发现58%患者PET阳性/MRI阳性,30%PET阳性/MRI阴性;PET/MRI与电临床假设一致率高,术后76%达Engel IA级。结论认为PET/MRI对MRI阴性或不确定病例有重要诊断和预后价值。

要点

  • 联合PET/MRI在58%患者中显示PET阳性/MRI阳性,30%为PET阳性/MRI阴性。
  • PET阳性/MRI阳性结果与电临床假设一致率达98%(45/46)。

核心结论

  • [18F]FDG PET/MRI在儿童局灶性癫痫术前评估中提供显著诊断和预后价值,尤其对MRI阴性或不确定病例。

研究设计与样本

  • 分析分四阶段:评估既往MRI(阶段0)、盲法判读PET/MRI所获MR序列(阶段1)、核医学/神经放射联合PET/MRI评估(阶段2)、对照致痫灶假设验证(阶段3)。

主要发现

  • 初始MRI不确定26例(33%),阴性53例(67%);盲法3-T MRI在36例(46%)发现可疑病灶,其中10例发现额外病灶。
  • 联合PET/MRI读片:PET阳性/MRI阳性46例(58%),PET阳性/MRI阴性24例(30%),PET阴性/MRI阴性8例(10%)。
  • PET/MRI显示代谢改变70例(89%):67/70(96%)为低代谢,6/70(9%)为低代谢与高代谢混合区域。
  • PET阳性/MRI阳性者与电临床假设一致45/46(98%),PET阳性/MRI阴性者一致15/24(63%)。

关键数值与推荐

  • PET阳性/MRI阳性结果在识别致痫病灶(尤其局灶性皮质发育不良)方面显示高准确性。
  • 患者平均癫痫病程4.4年,65例(83%)为药物难治性发作。

临床怎么用

  • 对MRI阴性或不确定的儿童局灶性癫痫,可考虑[18F]FDG PET/MRI辅助术前致痫灶定位。
  • 联合PET/MRI读片有助于提高术前评估精度并指导临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We hypothesized that [18F]FDG PET/MRI would improve presurgical lesion detection compared with MRI alone in pediatric patients with focal epilepsy. We analyzed surgical outcomes and the presurgical evaluation pipeline. Methods: We included pediatric patients undergoing [18F]FDG PET/MRI between January 2017 and October 2021. Eligible patients were 18 y or younger, had a diagnosis of focal epilepsy under surgical evaluation, and had a negative or inconclusive MRI result. Data analysis phases included evaluation of prior MRI data (phase 0), masked review of PET/MRI-acquired MR sequences (phase 1), joint (nuclear medicine/neuroradiology) PET/MRI assessment (phase 2), and verification of PET/MRI findings against the hypothesized epileptogenic zone (EZ) (through electroencephalography in all cases; through stereoelectroencephalography outcomes and histology when relevant) (phase 3). Results: Seventy-nine patients were included in the study (49 male; mean age, 9.5 y). Patients' mean duration of epilepsy was 4.4 y, and 65 (83%) had drug-resistant seizures. Initial MRI results were inconclusive in 26 (33%) patients and negative in 53 (67%) patients. Blinded 3-T MRI identified suspect lesions in 36 (46%) patients, identifying additional lesions in 10 patients. Joint PET/MRI reading revealed that 46 (58%) patients had concordant PET-positive/MRI-positive results, 24 (30%) had PET-positive/MRI-negative results, and 8(10%) had PET-negative/MRI-negative results. Concordant PET-positive/MRI-positive findings demonstrated high accuracy in identifying epileptogenic lesions, particularly focal cortical dysplasia. PET/MRI showed metabolic alterations in 70 (89%) patients: 67 of 70 (96%) with hypometabolism and 6 of 70 (9%) with mixed areas of hypometabolism and hypermetabolism. The results were concordant with the electroclinical hypothesis in 45 (98%) of 46 patients with PET-positive/MRI-positive results and in 15 (63%) of 24 patients with PET-positive/MRI-negative results. Twenty-four patients underwent resection or disconnection, and 5 underwent thermocoagulation. Of these, 22 (76%) achieved Engel Class IA outcomes (average follow-up, 2.1 y). Conclusion: [18F]FDG PET/MRI offered significant diagnostic and prognostic value, especially in MRI-negative or inconclusive cases, enhancing presurgical evaluation precision and guiding clinical decision-making in pediatric epilepsy surgery.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Luisi C, De Palma L, Campi C, et al. [18F]FDG PET/MRI in Pediatric Focal Epilepsies. J Nucl Med. 2026. PMID: 42276780. doi:10.2967/jnumed.125.271155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。